H. Lundbeck A/S
•internt ansatte repræsentanter og brancheforeninger, der er aktive inden for lobbyvirksomhed
II - In-house lobbyists and trade/business/professional associations
Companies & groups
Chairman with extended operational responsibilities
Global Public Affairs Director
H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical company highly committed to improve the quality of life for people suffering from disorders in the central nervous system (CNS). For this purpose Lundbeck is engaged in the research and development, production, marketing and sale of pharmaceuticals across the world, targeted at disorders like depression and anxiety, alcohol dependence, schizophrenia, insomnia, Huntington's, Alzheimer's and Parkinson's diseases.
Lundbeck was founded by Hans Lundbeck in 1915 in Copenhagen, Denmark, and today employs 5,900 people worldwide. Lundbeck is one of the world's leading pharmaceutical companies working with CNS disorders. In 2012, the company's revenue was DKK 14.8 billion. For more information, please visit www.lundbeck.com.
Legislation and public policy areas relevant for the pharmaceutical industry and Lundbeck's focus within central nervous system disorders, eg. mental health
|No accredited persons|
Efpia - European Federation of Pharmaceutical Industries and Associations
DI - Confederation of Danish Industry
Lif - The Danish Association of the pharmaceutical industry
Ifpma - International Federation of Pharmaceutical Manufacturers & Associations
01/2012 - 12/2012
300,000 € - 350,000 €
No funding received from the EU institutions during the last closed financial year.
By its registration the organisation has signed the Transparency Register Code of Conduct.